Navigation Links
University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
Date:7/7/2008

WHITE PLAINS, N.Y., July 7 /PRNewswire/ -- The Leukemia & Lymphoma Society has awarded a $550,000 grant to Jonathan Friedberg M.D., M.M.Sc., of the James P. Wilmot Cancer Center at the University of Rochester Medical Center. Millennium Pharmaceuticals, The Takeda Oncology Company, of Cambridge, Mass., is funding the first two years of the five-year program.

The Scholar in Clinical Research Career Development Grant will support Dr. Friedberg's work on a new targeted treatment for lymphoma patients.

Dr. Friedberg is studying the drug R788 for patients with indolent and mantle cell non-Hodgkin lymphoma (NHL). This drug inhibits the molecule called SYK, which controls the survival of B-cells in lymphoma patients. Dr. Friedberg has already shown in several patients that R788 is safe and effective. He is now using mouse models to evaluate R788 in combination with other agents to kill lymphoma cells even better. Once the most promising combination is identified, Dr. Friedberg will pursue a clinical trial enrolling patients with relapsed indolent and mantle cell NHL.

"To effectively eradicate cancers we must learn which molecules cause them and then develop new treatments that kill cancer cells without harming healthy cells," said Barton Kamen, M.D., PhD, Chief Medical Officer of LLS. "Dr. Friedberg's work shows exceptional promise and is likely to lead to improved treatments for patients with various types of lymphoma."

Friedberg is Associate Professor of Medicine, and Director of Hematological Malignancies Clinical Research at the Wilmot Cancer Center. He is leading a number of clinical studies of new agents for lymphoma patients.

The LLS Career Development Program funds talented investigators at different points in their developing careers: Fellows and Special Fellows during their post-doctoral training years, and Scholars and Scholars in Clinical Research early in their independent academic positions. The program thereby recruits and supports young scientists in blood cancer research, helping to populate the field with the best and brightest young researchers who are accomplishing cutting-edge research in established and new laboratories.

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society(R), headquartered in White Plains, NY, with 67 chapters in the United States and Canada, is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, LLS has invested more than $600 million in research specifically targeting leukemia, lymphoma and myeloma. Last year alone, LLS made 5.1 million contacts with patients, caregivers and healthcare professionals.

For more information about blood cancer, visit http://www.LLS.org or call the LLS Information Resource Center (IRC), a call center staffed by master's level social workers, nurses and health educators who provide information, support and resources to patients and their families and caregivers. IRC information specialists are available at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.

Contact: Andrea Greif

914.821.8958

andrea.greif@lls.org


'/>"/>
SOURCE The Leukemia & Lymphoma Society
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
2. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
3. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
4. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
5. Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany
6. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
7. Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
8. BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University
9. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
10. Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
11. Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset ... of specialty vendors and unique items from across the nation, this holiday-themed event will ... services offered by the VNA. The boutique will be open Saturday, November 4 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the ... today its plans to open a flagship location in Covington, LA at 401 N. ... To Go store next to Office Depot in the Holiday Square shopping center. Its ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... GRAND RAPIDS, Mich. (PRWEB) , ... October 12, ... ... OnSite Wellness, has been named one of Michigan’s 2017 Best and Brightest in ... Best and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 ...
Breaking Medicine News(10 mins):